Dear Climb community,
As the world continues to respond to the COVID-19 crisis, the uncertainty of the past few months has reminded me of what’s truly important — stepping forward and caring for our loved ones and neighbors. In this moment, nothing is more important.
This pandemic has changed all our lives, and it’s also changed Climb to Fight Cancer’s plans. Fred Hutch has made the decision to postpone all of our 2020 climbs.
While we are not able to be together right now, our Climb network remains a source of inspiration and connection. This emergency will pass, and the mountains will be there to enjoy once again. Until then, we must work together to safeguard the health of our community.
We need fearless science now more than ever. Hutch scientists are on the frontlines of this pandemic, balancing this urgent work with our core mission of advancing discoveries and curing cancer. I want to share an update with you about some of their exciting new research. Dr. Julie McElrath is leading the Seattle COVID-19 Cohort Study, which aims to decode the interaction between the virus and the immune system by studying people who are at high risk of exposure, as well as those who have already contracted the disease. Dr. Neelendu “Neel” Dey is piloting a “fail fast” study to explore whether it’s possible to target the microbiome to help patients recover more quickly or reduce the virus’s chance of spreading through fecal transmission. And Dr. Vivian Oehler is testing a broad panel of FDA-approved cancer drugs against COVID-19 to find treatments that could be effective in early-stage infection. Climb funding is critical to this important work.
I know this crisis has taken an enormous toll on all of us, but I’m inspired by the decisive actions of city and state officials, public health experts, Fred Hutch leaders, and our fellow citizens. These decisions are saving lives.
Thank you again for all you do for Fred Hutch and Climb to Fight Cancer. Please continue to take good care of yourself and your loved ones.
Climb to Fight Cancer Manager